Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner, ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry
As the UK Government tries desperately to salvage a shattered economy, an unlikely but profitable lifeline presents itself as the medical cannabis industry booms.
In the last decade, the medical cannabis market has matured in North America, producing impressively high yield results for both the patients and economies alike. Meanwhile, in the UK, the sector lies tantalisingly close to unlocking the full potential of the market.
Sativa Wellness Group is focused on developing consumer products under the core “Goodbody” brand. The Goodbody brands are available online and in a growing number of retailers across the UK, all with the commitment of “CBD you can Trust”.